An abnormal production of Aβ42 leads to the formation of senile plaques and was supposed to trigger a cascade of processes such as inflammation, oxidative stress, and Tau protein accumulation, leading to neuronal loss and finally to AD symptoms [49]. This evidence concerns the gene MAPT and Alzheimer disease.